Category Lobbying

Questions About Funding, Text Of Tufts Study On Drug Costs

The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.

WHO Sets Path For Completing Rules Of Engagement With Industry, Foundations

The World Health Organization Executive Board has set a way forward from now to the annual May World Health Assembly for addressing the sensitive issue of drafting a framework for engagement with “non-state actors,” such as industry, foundations, academics and other non-governmental stakeholders.

Antimicrobial Resistance, Budget, Reform Raise Debate At WHO Executive Board

The World Health Organization Executive Board this week has addressed the relationship between the UN agency and its funders and lobbyists, examined the budget for the next biennium, and looked at the issue of the growing resistance of bacteria to…

Geneva Forecast On Internet Governance: 2015 Expected To Be A Decisive Year

A Geneva expert has offered his view on the top internet governance issues likely to come up in 2015. These include: cybersecurity, privacy, internet neutrality, and the proposed transition of control over a key underlying aspect of the internet.

Ebola, Reform High On WHO Executive Board Agenda This Week

The World Health Organization Executive Board yesterday adopted a resolution on Ebola, on the eve of today’s opening of its 10-day meeting addressing a broad range of health issues, including several of relevance to the intellectual property and innovation community. Today, Italy requested that member states be involved in the setting of WHO guidelines, raising governance issues, while WHO Director General Margaret Chan called for strong health systems and reform to the WHO structure, and asked for room to move on WHO relations with industry.

Year Ahead: Big IP Developments Loom For US Law In 2015

2014 brought major changes to the United States intellectual property system, particularly in the area of patent law. 2015 promises more of the same, as the new Supreme Court ruling in Teva Pharmaceuticals USA v. Sandoz attests. Here’s a discussion of Teva and other key cases and developments to watch this year.

Year Ahead: Copyright Reform, EPO Governance, Trade Secrets Among Top European IP Issues In 2015

Review, and possibly reform, of the European Union copyright system tops the list of “hot” European intellectual property issues this year. The new European Commission has made modernising copyright rules a major priority, while fresh debate has broken out over the need for levies on digital copying devices to remunerate rights holders.

Meanwhile ongoing unrest between European Patent Office (EPO) staff and management looks likely to continue, as do efforts to finalise the unitary European patent and Unified Patent Court. EU legislation to protect trade secrets could be adopted and trademark law updated. In addition, several important IP-related decisions are expected from the European Court of Justice (ECJ).

WHO Executive Board To Address Reform, R&D Financing, Ebola, Budget

The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.

Top European IP Experts Hail CEIPI’s 50 Years With Vision, Suggestions For IP System

The celebration late last year of the 50th anniversary of the Centre de Études Internationales de la Propriété Intellectuelle (CEIPI) at the Université de Strasbourg, France, brought together leading figures in the European IP community. Speakers hailed the origin and successes of the IP system in Europe, and had suggestions for what do better going forward.